Summary Chronic kidney disease due to other and unspecified causes was responsible for 11·6 million (95% UI 9·70–13·7) DALYs in 2019.

Definition This cause incorporates death and disability due to chronic kidney disease that is due to unknown or unspecified aetiologies.

Total sources
Incidence 0
Prevalence 0
Remission 0
Causes of death 0
Other 356
Table 1: Total sources used in GBD 2019 estimation
What is new in GBD 2019?
  • •Excess mortality data (EMR) were modelled in MR-BRT by age and sex as a function of HAQ Index.
  • •Adjustments for alternative CKD estimating equations were applied prior to DisMod-MR. These adjustments increased estimates for stage 3 but resulted in small changes for stages 4 and 5 compared to previous rounds of GBD. The reference equation is CKD-EPI.
Prevalence
Incidence
Deaths
YLLs
YLDs
DALYs
Cases
(millions)
Rate (per 100 000)
Cases
(millions)
Rate (per 100 000)
Deaths
(millions)
Rate (per 100 000)
YLLs
(millions)
Rate (per 100 000)
YLDs
(millions)
Rate (per 100 000)
DALYs
(millions)
Rate (per 100 000)
2019
Both Sexes
514
(478
to 548)
6342·1
(5905·8
to 6753·8)
14·2
(13·1
to 15·3)
174·4
(161·7
to 188·1)
0·305
(0·238
to 0·383)
4·0
(3·1
to 5·0)
7·81
(6·39
to 9·56)
98·9
(81·4
to 120·1)
3·77
(2·75
to 4·93)
47·4
(34·6
to 61·6)
11·6
(9·70
to 13·7)
146·2
(123·4
to 172·1)
Females
291
(271
to 310)
6896·3
(6414·2
to 7345·6)
8·22
(7·62
to 8·86)
191·3
(177·5
to 205·9)
0·151
(0·118
to 0·189)
3·5
(2·8
to 4·4)
3·64
(2·96
to 4·43)
88·8
(72·6
to 107·5)
2·26
(1·66
to 2·92)
54·6
(40·0
to 70·5)
5·90
(4·95
to 6·93)
143·4
(120·4
to 167·8)
Males
222
(207
to 238)
5741·0
(5352·9
to 6127·3)
5·96
(5·49
to 6·47)
156·1
(144·2
to 169·0)
0·155
(0·121
to 0·196)
4·5
(3·5
to 5·8)
4·17
(3·34
to 5·15)
110·4
(89·6
to 135·7)
1·51
(1·10
to 1·97)
40·0
(29·2
to 52·2)
5·68
(4·72
to 6·79)
150·4
(126·2
to 179·1)
Percentage change 2010-19
Both Sexes
24·4%
(23·4
to 25·4)
2·8%
(2·4
to 3·2)
33·8%
(32·5
to 35·1)
5·8%
(5·1
to 6·4)
22·9%
(15·6
to 29·7)
–4·7%
(–9·8
to 0·4)
12·6%
(5·2
to 19·9)
–5·6%
(–11·2
to 0·3)
19·2%
(17·0
to 21·3)
–0·3%
(–1·8
to 1·4)
14·7%
(9·6
to 19·7)
–3·9%
(–7·8
to 0·1)
Females
24·2%
(23·1
to 25·3)
2·5%
(2·0
to 3·1)
32·0%
(30·5
to 33·5)
4·9%
(3·9
to 5·8)
24·3%
(15·8
to 32·8)
–3·7%
(–10·1
to 3·0)
14·4%
(5·3
to 24·0)
–4·5%
(–11·8
to 3·4)
19·2%
(16·7
to 21·7)
0·2%
(–1·5
to 1·9)
16·2%
(10·3
to 22·5)
–2·8%
(–7·6
to 2·2)
Males
24·8%
(23·6
to 25·8)
3·2%
(2·7
to 3·7)
36·4%
(35·1
to 37·6)
7·2%
(6·5
to 7·9)
21·6%
(13·4
to 29·8)
–5·9%
(–11·7
to –0·1)
11·1%
(2·9
to 20·0)
–6·6%
(–13·0
to 0·2)
19·2%
(16·6
to 21·8)
–0·9%
(–2·7
to 1·1)
13·1%
(7·1
to 20·0)
–5·2%
(–9·9
to –0·1)
Numbers in parentheses are 95% uncertainty intervals.
Table 2: Global prevalence, incidence, deaths, YLLs, YLDs, and DALYs in counts and age-standardised rates for both sexes combined, females, and males, 2019, with percentage change between 2010 and 2019
Deaths YLLs YLDs DALYs
1990 56th 68th 75th 72nd
2010 44th 54th 58th 58th
2019 38th 49th 57th 49th
Table 3: Rank among most detailed causes for global deaths, YLLs, YLDs, and DALYs in 1990, 2010, and 2019, for both sexes combined
Figure 1: Composition of DALYs by YLLs and constituent sequelae YLDs for both sexes combined, 2019
Figure 2: Percentage of DALYs attributable to top risk factors for both sexes combined, 2019
No Legend
Figure 3: Age-standardised DALY rates for each location by SDI, both sexes combined, 2019
Figure 4: Composition of DALYs by YLLs and YLDs, age group, and sex, 2019
No Legend
Figure 5: Age-standardised DALY rates (per 100 000) by location, both sexes combined, 2019